In the news | 3rd July 2019
Streamlining biopharmaceutical data management in 2021
Graeme Dennis, IDBS, tells Pharmafield why an overhaul in biopharmaceutical data management is necessary in 2021.
More news
Biologics are changing our world. How can we speed up their development?
The global pandemic is shining a spotlight on the power of biologics, both vaccines and antibody therapeutics, to prevent serious infections and treat disease.
IDBS and Scitara announce a strategic partnership to integrate the Scitara Digital Lab Exchange (DLX![™]()
) platform with Polar![™]()
, IDBS’ Biopharmaceutical Lifecycle Management (BPLM) platform
) platform with PolarThe licensing and integration of Scitara DLX technology will offer IDBS users plug-and-play connectivity to any instrument or application in regulated and non-regulated laboratories
Strategic Partnership Between Genedata and IDBS Aims to Further Streamline Biopharma Discovery, Development and Manufacturing
The collaboration will enable direct integration of IDBS digital solutions with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland & Boston, MA, USA — January 12, 2021 — Genedata and IDBS, both…
The post Streamlining biopharmaceutical data management in 2021 appeared first on IDBS.